Oral Topotecan With Toripalimab for Patients With Endometrial Cancer

Summary

This study aims to explore the safety and efficacy of oral topotecan combined with toripalimab in treating advanced/recurrent endometrial cancer through a single-center, prospective, single-arm, phase II clinical trial. The goal is to explore the first-line treatment options for endometrial cancer patients in the era of immunotherapy, to improve the overall treatment level and prognosis of endometrial cancer.

Timeline

Start

2024-11-30

Primary completion

2026-06-30

Completion

2026-12-31

Drugs

Indications